GentleMed
Baltimore
About GentleMed
GentleMed creates the AccuEye to meet patient. What if you were one of the 60 Million people going blind because of Glaucoma? The precision of each drop is the difference between blindness and sight. In the U.S. alone, the glaucoma treatment market is worth $2.9 billion. Eye drops are easy to forget and difficult to apply. They have created the AccuEye to meet patients needs. Their low risk, Class I device has easy entry into the market. If half of todays non-compliant patients become compliant with AccuEye, healthcare will save $1B each year
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Last round: Grant (Nov 2010)
Industries & Categories
Health Care, Life Science
Canonical: https://fsome.com/organization/gentlemed-1776125 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.